| ARCT Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ARCT shares outstanding history going back to 12/31/2017:
Also see: ARCT Market Cap History ARCT YTD Return |
ARCT Shares Outstanding History — Arcturus Therapeutics Share Count Over Time
As of 5/5/2026 Arcturus Therapeutics has 28.42 million ARCT shares outstanding. Investors often track the ARCT shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ARCT share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 12/31/2017.
| ARCT Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARCT Historical Shares Outstanding: +12.42% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ARCT Stock Price Chart |
| About Arcturus Therapeutics Holdings Inc |
| Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. Co. is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. We show 31 historical shares outstanding datapoints in our coverage of ARCT's shares outstanding history. Understanding the changing numbers of ARCT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARCT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARCT by allowing them to research ARCT shares outstanding history as well as any other stock in our coverage universe. |
| ARCT Current Stock Quote |
Quotes delayed 20 minutes  Free ARCT Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ARCT Share Performance |
| Shares Outstanding Peers |
| Arcturus Therapeutics (ARCT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ARDM Shares Outstanding History ARDS Shares Outstanding History ARDT Shares Outstanding History ARDX Shares Outstanding History ARMO Shares Outstanding History ARNA Shares Outstanding History ARPO Shares Outstanding History ARQL Shares Outstanding History ARQT Shares Outstanding History ARTL Shares Outstanding History More Healthcare companies » |
ARCT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
